Latest Press Releases
More Press Releases
Moolec Science SA in Voluntary Liquidation Announces Receipt of Nasdaq Delisting Determination Following Approval of Voluntary Liquidation
GRAND CAYMAN, CAYMAN ISLANDS / ACCESS Newswire / November 2, 2026 / Moolec Science SA in Voluntary Liquidation
American Vanguard Announces Date of Third Quarter 2026 Earnings Release and Webcast Conference Call
IRVINE, CA / ACCESS Newswire / November 2, 2026 / American Vanguard Corporation announced today that it will report
Aehr Test Systems Reports Record First Quarter Fiscal 2027 Revenue of $33.0 Million; Raises Full-Year Revenue Outlook to $150 Million, Triple Fiscal 2026 Revenue
Strong Quarterly Bookings of $46.7 Million; Effective Backlog Reaches $109.3 Million FREMONT, CA / ACCESS Newswire /
Isabella Bank Corporation Announces Completion of Merger with Grand River Commerce, Inc. and the Results of Merger Consideration Elections
MOUNT PLEASANT, MI / ACCESS Newswire / November 2, 2026 / Isabella Bank Corporation (the "Company" or "Isabella")
CXApp Inc. (NASDAQ: CXAI) Announces Webcast and Dial-In Details for Third Quarter 2026 Financial Results and Business Update Conference Call
Chairman and CEO Khurram Sheikh will host the live call on Wednesday, November 4, 2026 at 1:30 p.m. Pacific Time / 4:30
CW Resort & Marina Announces Grand Opening Celebration in Clearwater Beach
November 14 celebration features ribbon cutting, live music, HJ Yang Gallery, fine art book signing and a special 50%
American Saltwater Guides Association “Menhaden Math” Leaves Out Half the Equation
WASHINGTON, D.C. / ACCESS Newswire / November 2, 2026 / The American Saltwater Guides Association's podcast, The Guide
Osisko Gold Appoints Vice President, Construction Operations for the Cariboo Gold Project
TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) — Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
Fort Lee, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a